Position in TNYA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,966,557
-$888,282 QoQ
Shares Held
4,286,933
-20.8% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
3.60%
of 13F equity value
Holder Rank
#3
of 103 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Empery Asset Management, LP holds $53,120,730 across 6 Biotechnology names. TNYA ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XFOR |
X4 Pharmaceuticals, Inc
|
8,944,118 | $36,939,207 | |
| 2 | DTIL |
Precision Biosciences Inc
|
1,968,879 | $10,828,834 | |
| 3 | TNYA |
Tenaya Therapeutics, Inc.
This page
|
4,286,933 | $2,966,557 | |
| 4 | MSLE |
Satellos Bioscience Inc.
|
230,100 | $1,295,463 | |
| 5 | PMN |
ProMIS Neurosciences Inc.
|
60,353 | $766,483 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
30,440 | $324,186 |
All Filings in TNYA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,966,557 | 4,286,933 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,854,839 | 5,414,101 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $5,069,024 | 8,296,276 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,974,568 | 8,727,314 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||